Resveratrol for Alzheimer's disease?
1Department of Neurology, Jungers Center for Neurosciences Research, Parkinson Center of Oregon, Oregon Health & Science University, Portland, OR 97239, USA.
Science Translational Medicine
|February 3, 2017
Summary
Resveratrol, an antioxidant, was found to reduce harmful beta-amyloid and inflammation in Alzheimer's patients. This suggests a potential therapeutic role for resveratrol in managing Alzheimer's disease progression.
Area of Science:
- Neuroscience
- Pharmacology
- Biochemistry
Background:
- Alzheimer's disease is characterized by the accumulation of beta-amyloid plaques and neuroinflammation.
- Current treatments for Alzheimer's disease offer limited efficacy in halting disease progression.
- Resveratrol, a natural polyphenol, exhibits antioxidant and anti-inflammatory properties.
Purpose of the Study:
- To investigate the effects of resveratrol on beta-amyloid levels in patients with Alzheimer's disease.
- To assess the impact of resveratrol on key inflammatory markers in Alzheimer's disease patients.
Main Methods:
- A clinical study involving patients diagnosed with Alzheimer's disease.
- Administration of resveratrol to the study participants.
- Measurement of beta-amyloid concentrations and inflammatory markers in patient samples.
Main Results:
- Resveratrol administration led to a significant modulation of beta-amyloid levels.
- Key inflammatory markers were reduced in patients treated with resveratrol.
- The observed changes suggest a positive impact on the pathological processes of Alzheimer's disease.
Conclusions:
- Resveratrol demonstrates potential in managing Alzheimer's disease by targeting beta-amyloid and inflammation.
- These findings support further research into resveratrol as a therapeutic agent for Alzheimer's disease.
Related Concept Videos
01:22Alzheimer's Disease: Treatment
1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
01:26Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
01:26Atherosclerosis III: Management
540
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
540
02:30siRNA - Small Interfering RNAs
18.9K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.9K
01:24Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K